Clinical Trial Update: Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase 1/2 clinical trial evaluating the combination of liposomal doxorubicin and trastuzumab for women with locally advanced, inflammatory, or metasta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxil (liposomal doxorubicin)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED